Roche moves future Germany investments ‘on hold’

FRANKFURT, Oct 19 (Reuters) Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies, the ​company s Germany chief said in an ‌interview with newspaper Welt that was published on Monday. We have put all future investment decisions in Germany on hold for the time ‌being, ​said Daniel Steiners, head ⁠of Roche Germany, adding ⁠that for the pharmaceutical industry, policy makers had recently destroyed a lot of trust . • Steiners said that instead of tackling ​the structural problems of the statutory health insurance system, policy makers are ⁠focusing on short-term savings ⁠and placing additional burdens on ​the industry • A so-called ‘location clause’, which could exempt ​domestically producing pharmaceutical companies from manufacturer ‌discounts, would only partially offset the negative effects of the legislation, needed is a comprehensive strategy, he added • Following proposed ⁠legislation in Germany to cap rapidly growing costs i